drugset / Trial / NCT00255554

DBT and Escitalopram in Borderline Personality Disorder

NCT00255554

RandomizedParallel-groupDouble-blindTreatment

Summary

Subjects will receive six months of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist. Half the subjects will concurrently receive escitalopram while half will receive placebo, in a randomized double-blind design.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule